The Effect of Diabetes Mellitus on Costs and Length of Stay in Patients with Peripheral Arterial Disease Undergoing Vascular Surgery

被引:45
作者
Malone, M. [1 ,2 ]
Lau, N. S. [2 ,3 ]
White, J. [1 ,2 ]
Novak, A.
Xuan, W. [2 ]
Iliopoulos, J. [2 ,4 ]
Crozier, J. [2 ,4 ]
Dickson, H. G. [2 ,5 ]
机构
[1] Liverpool Hosp, High Risk Foot Serv, Liverpool, NSW 2170, Australia
[2] Ingham Inst Appl Med Res, LIVE DIAB CRU, Liverpool, NSW, Australia
[3] Liverpool Hosp, Diabet & Endocrine Serv, Liverpool, NSW 2170, Australia
[4] Western Hlth, Diabet Foot Serv, Melbourne, Vic, Australia
[5] Liverpool Hosp, Liverpool, NSW 2170, Australia
关键词
Diabetes mellitus; Economics; Length of stay; Lower limb; Peripheral arterial disease; Vascular surgery; PREVALENCE; CARE; HYPERGLYCEMIA;
D O I
10.1016/j.ejvs.2014.07.001
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: To determine the impact of diabetes mellitus (DM) and other comorbidities on length of stay (LOS) and costs in patients with peripheral arterial disease (PAD) admitted to a vascular surgical unit. Methods: A retrospective study was conducted between January 2011 and July 2012 at a tertiary referral hospital in Sydney. Demographic, laboratory, and operative data were obtained from the Australasian Vascular Audit database and hospital diagnostic-related group (DRG) reports. Patients with confirmed PAD with or without DM requiring hospital admission for a diagnosis of claudication, rest pain, ulcer/gangrene, and infection that required lower limb surgical intervention were included. Associations between LOS, surgical procedure, and DRG were explored. Results: Five hundred and sixty-eight admissions (492 patients) were identified: 292 admissions with PAD and 276 admissions with PAD in conjunction with DM (PADDM). Mean LOS for patients with PAD was 10 +/- 13.7 days compared with 15 +/- 8.2 days for PADDM (p<.01; 95% confidence interval 2.7-8.0). LOS and costs were greatest in patients with PADDM undergoing major amputation (37 +/- 3.7 days; US$42,236; p<.01). Analysis of variance indicated that the best predictors of LOS were the presence of DM, bypass surgery, amputation, chronic kidney disease (CKD) stage V, infection, and emergency admission. Over 18 months, the estimated total inpatient costs associated with lower limb intervention for PAD with and without DM amounted to US$7,598,597. People with DM incurred greater inpatient costs, averaging US$1,912 more per episode of admission and a total of US$528,029 over 18 months. Conclusion: The impact of diabetes as a comorbid condition in patients with PAD is significant, both clinically and economically. Factors that predict increased LOS in patients with PAD are DM, bypass surgery, amputation, CKD stage V, infection, and emergency admission. (C) 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:447 / 451
页数:5
相关论文
共 50 条
  • [21] Amputation-Free Survival in Patients With Diabetes Mellitus and Peripheral Arterial Disease With Heel Ulcer: Open Versus Endovascular Surgery
    Butt, Talha
    Lilja, Erika
    Orneholm, Hedvig
    Apelqvist, Jan
    Gottsater, Anders
    Eneroth, Magnus
    Acosta, Stefan
    VASCULAR AND ENDOVASCULAR SURGERY, 2019, 53 (02) : 118 - 125
  • [22] The Correlation of Short-Chain Fatty Acids with Peripheral Arterial Disease in Diabetes Mellitus Patients
    Muradi, Akhmadu
    Jasirwan, Chyntia Olivia Maurine
    Simanjuntak, Charley D.
    Pratama, Dedy
    Suhartono, Raden
    Darwis, Patrianef
    Kekalih, Aria
    LIFE-BASEL, 2022, 12 (10):
  • [23] Coronary artery revascularization before peripheral vascular surgery in patients with peripheral arterial disease
    Hideki Miyachi
    Jun Tanabe
    Eitaro Kodani
    Yusuke Hosokawa
    Mitsunobu Kitamura
    Asako Sasaki
    Michio Ogano
    Kunito Shiiba
    Hisato Takagi
    Takuya Umemoto
    Yoshiki Kusama
    Kyoichi Mizuno
    Cardiovascular Intervention and Therapeutics, 2010, 25 (1) : 11 - 17
  • [24] Coronary artery revascularization before peripheral vascular surgery in patients with peripheral arterial disease
    Miyachi, Hideki
    Tanabe, Jun
    Kodani, Eitaro
    Hosokawa, Yusuke
    Kitamura, Mitsunobu
    Sasaki, Asako
    Ogano, Michio
    Shiiba, K.
    Takagi, Hisato
    Umemoto, Takuya
    Kusama, Yoshiki
    Mizuno, Kyoichi
    CARDIOVASCULAR INTERVENTION AND THERAPEUTICS, 2010, 25 (01) : 11 - 17
  • [25] An Evaluation of Biomarkers as Determinants of Peripheral Arterial Disease in those with Diabetes Mellitus
    Ahmad, Shabbir
    Zaib, Sumera
    CHEMISTRYSELECT, 2023, 8 (13):
  • [26] Peripheral vascular disease and Type 2 diabetes mellitus
    Schaper, NC
    Nabuurs-Franssen, MH
    Huijberts, MSP
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2000, 16 : S11 - S15
  • [27] Cost of hospitalisation and length of stay due to hypoglycaemia in patients with diabetes mellitus: a cross-sectional study
    Naser, Abdallah Y.
    Alwafi, Hassan
    Alsairafi, Zahra
    PHARMACY PRACTICE-GRANADA, 2020, 18 (02):
  • [28] Diabetes Mellitus and Peripheral Vascular Disease Diagnosis and Management
    Chin, Jason A.
    Sumpio, Bauer E.
    CLINICS IN PODIATRIC MEDICINE AND SURGERY, 2014, 31 (01) : 11 - +
  • [29] Vascular diseases in diabetes patients: Special aspects of peripheral arterial disease (PAD)
    Espinola-Klein, Christine
    DIABETOLOGIE, 2024, : 293 - 302
  • [30] Effect of comorbidity assessed by the Charlson Comorbidity Index on the length of stay, costs, and mortality among colorectal cancer patients undergoing colorectal surgery
    Zhang, Xuexue
    Wang, Xujie
    Wang, Miaoran
    Gu, Jiyu
    Guo, Huijun
    Yang, Yufei
    Liu, Jian
    Li, Qiuyan
    CURRENT MEDICAL RESEARCH AND OPINION, 2023, 39 (02) : 187 - 195